DETECT—New Pathways to Early Detection and Intervention in Alzheimer’s Disease

Thursday, April 30, 2026

6:00 PM – 6:30 PM Registration & Dinner
6:30 PM – 8:30 PM Educational Program

Seattle Marriott Waterfront
2100 Alaskan Way
Seattle, Washington 98121
Meeting Room: Grand Ballroom D

PROGRAM FEATURES

2.0 CME/CNE CREDITS
Complimentary Dinner

PRESENTING FACULTY

	Program Chair Brad Dickerson, MD, MMSc, FAAN Director, Massachusetts General Hospital Frontotemporal Disorders Unit Professor of Neurology, Harvard Medical School Boston, Massachusetts
	Alireza Atri, MD, PhD Chief Medical Officer, Banner Research Banner Alzheimer’s and Research Institutes Phoenix, Sun City, and Tucson, AZ Director, Banner Sun Health Research Institute Sun City, Arizona

PROGRAM OVERVIEW

The DETECT live SUMMITS will feature a series of regional, case-based, interactive meetings across three targeted tracks—Primary Care (screening and referral), Neurology (diagnosis and treatment), and Multidisciplinary Teams (care coordination and shared decision-making). Designed to address real-world barriers identified through behavioral science analyses and qualitative research, this series will convene local providers to develop practical solutions that improve referral pathways, diagnostic confidence, and team-based Alzheimer’s care. To sustain impact, participants will join the Insights-to-Action Platform, an online collaboration hub that enables ongoing networking, resource sharing, and implementation of best practices across regions.

TARGET AUDIENCE

This activity is tailored to meet the educational needs of neurologists, primary care physicians, geriatricians, psychiatrists, neuroradiologists, nurses, nurse practitioners, and physician assistants.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Implement evidence-based strategies for screening, diagnosing, and staging MCI and AD that integrate clinical assessment with objective cognitive and biomarker testing
• Apply the latest clinical practice recommendations for the use of DMTs for AD, including criteria for appropriate patient selection
• Develop strategies to identify, monitor, and manage AEs associated with DMTs for AD, particularly ARIA
• Formulate best practices for a multidisciplinary approach that incorporates SDM when discussing the treatment options and management of AD

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 2.0 ANCC contact hours.

AAPA CREDIT DESIGNATION STATEMENT – Live

Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits.

ACCME INNOVATION PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

ACCME INNOVATION PARTNER DISCLAIMER

Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]